Where does Medipal Holdings Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Medipal Holdings Corporation ranks #2,412 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Medipal Holdings Corporation hold?

Medipal Holdings Corporation holds 162 US utility patents granted between 2015 and 2025, spanning 54 technology areas.

What is Medipal Holdings Corporation's Innovation Score?

Medipal Holdings Corporation has an Innovation Score of 55.6 out of 100 (top 7% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Medipal Holdings Corporation focus on?

Medipal Holdings Corporation's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 84 patents, ranking #213 of 7,127 assignees active in that subclass. Grants appear in 54 CPC subclasses total.

Is Medipal Holdings Corporation's patent grant rate increasing or decreasing?

Medipal Holdings Corporation's recent grant velocity is -59% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Medipal Holdings Corporation's patents?

Medipal Holdings Corporation's patents average 14.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Medipal Holdings Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Medipal Holdings Corporation

USPTO PatentsView assignee record - 162 granted patents across 54 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Medipal ranks #2,412 of 49,997 tracked US assignees by granted-patent volume, with 162 patents across 54 technology areas.

#2,412
of 49,997 US assignees by volume: Top 7%
by Innovation Score (55.6/100): 14.3
avg claims per patent: -59%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2412 · Foreign Corporation #2,412 · 162 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MID 162 grants
TOP-DECILE #2,412/49,997
PHOTO-FINISH Embraer
CPC-WIDE A61B · 54 areas
INNOV-PAR 55.6/100
CLAIMS-RICH 14.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -59% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Embraer S.A. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Medipal’s 55.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 17.6 pts (32%) Velocity 4.4 pts (8%) Breadth 25.0 pts (45%) Claim depth 8.5 pts (15%)

Qualcomm Incorporated · highest

85
Proofpoint · near

56
Medipal Holdings · this assignee

56
Rebellions · near

56
Sony Europe B V · near

56
Streem · near

56
3D Lighting… · lowest

7

What this shows Medipal's Innovation Score is 55.6/100 (top 7% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Medipal?

Each dot is one of Medipal’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Medipal’s own 14.3 claims/patent is ABOVE the 13.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Medipal vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

How Medipal's grant cadence moved

Between 2020–2024, Medipal Holdings Corporation received 46 grants versus 111 in 2015–2019 (-59% equal-window velocity, below median growth). Across complete PatentsView years, output peaked in 2016 at 35 grants and bottomed in 2023 at 5. Lead class A61B accounts for 51.9% of the portfolio across 54 subclasses. Volume neighbours: Embraer S.A. (#2,408) and Thomas & Betts International LLC (#2,416).

Medipal's three-year grant acceleration

From 2019–2021 to 2022–2024, Medipal Holdings Corporation moved from 36 to 24 grants (0.67x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,254. See the growth leaderboard.

Embraer

162
Faurecia Interieu…

162
Firestone Industr…

162
Hayward Industries

162
Shiroki

162
Spin Master

162
Sambanova Systems

162
Thomas & Betts In…

162
Medipal Holdings ◀

162

What this shows Medipal holds 162 patents at rank #2,412, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Medipal

By rank, the assignees closest to #2,412 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Medipal's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Medipal, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Medipal ranks #213 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (56 here).

Rebellions Inc. 56 Streem, LLC 56 Sony Europe B.V. 56 Proofpoint, Inc. 56

Similar claim depth

Nearest assignees by average claims per patent (14.3 here).

AutoStore Technology AS 14.3 avg Benteler Automobiltechnik GMBH 14.3 avg Stepan Company 14.3 avg Fluke Corporation 14.3 avg

Medipal's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

56 Top 7% higher than 93% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Medipal Holdings Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	21	13.0%
2016	35	21.6%
2017	21	13.0%
2018	20	12.3%
2019	14	8.6%
2020	11	6.8%
2021	11	6.8%
2022	8	4.9%
2023	5	3.1%
2024	11	6.8%
2025partial year	5	3.1%

Which technologies does Medipal Holdings Corporation patent most?

A61B - DIAGNOSIS; SURGERY; Identification 84

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 30

H04N - Pictorial Communication, e.g. Television 23

G06T - Image Data Processing OR Generation, IN General 14

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 12

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 10

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 9

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 8

G06F - Electric Digital Data Processing 8

H04H - Broadcast Communication 8

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 7

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 6

F16B - Devices FOR Fastening OR Securing Constructional Elements OR Machine Parts Together, e.g. Nails, Bolts, Circlips, Clamps, Clips OR WEDGES; Joints OR Jointing 6

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 5

F25D - REFRIGERATORS; Cold ROOMS; ICE-BOXES; Cooling OR Freezing Apparatus NOT Otherwise Provided FOR 5

Top 15 of 54 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Medipal Holdings Corporation's patent record in context - here's where to go next.

Medipal Holdings Corporation's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 51.9% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #2,412 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Medipal Holdings Corporation against Embraer S.A., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 55.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.